Mutual independence of 5-HT2 and α1 noradrenergic receptors in mediating deficits in sensorimotor gating

Advances in endophenotyping schizophrenia

(2015) DAVID L. BRAFF et al.   World Psychiatry

The role of the central noradrenergic system in behavioral inhibition

(2011) Eric A. Stone et al.   BRAIN RESEARCH REVIEWS

Discrete Forebrain Neuronal Networks Supporting Noradrenergic Regulation of Sensorimotor Gating

(2011) Karen M Alsene et al.   NEUROPSYCHOPHARMACOLOGY

Ventral Striatal Noradrenergic Mechanisms Contribute to Sensorimotor Gating Deficits Induced by Amphetamine

(2010) Karen M Alsene et al.   NEUROPSYCHOPHARMACOLOGY

Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance

(2009) Siobhan Briody et al.   BEHAVIOURAL BRAIN RESEARCH

Marked behavioral activation from inhibitory stimulation of locus coeruleus α1-adrenoceptors by a full agonist

(2009) Eric A. Stone et al.   BRAIN RESEARCH

Activation of adenosine1 (A1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats

(2009) Gerard J. Marek   NEUROPHARMACOLOGY

Developing translational animal models for symptoms of schizophrenia or bipolar mania

(2009) Mark A. Geyer   NEUROTOXICITY RESEARCH

Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

(2009) M. van den Buuse   SCHIZOPHRENIA BULLETIN

From genes to psychoses and back: the role of the 5HT2α-receptor and prepulse inhibition in schizophrenia

(2008) Wolfgang Maier et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Effect of Aripiprazole on 5-HT2 Receptor–mediated Wet-Dog Shake Responses and Disruption of Prepulse Inhibition in Rats

(2008) Shuntaro Kohnomi et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

(2008) Neal R. Swerdlow et al.   PSYCHOPHARMACOLOGY

Pharmacological characterization and CNS effects of a novel highly selective α2C-adrenoceptor antagonist JP-1302

(2007) J Sallinen et al.   BRITISH JOURNAL OF PHARMACOLOGY